JACKIE stated a readout of Dep Docetaxel and one indication of Dep Cabazitaxel by June 30th 2022 and balance of Dep Cabazitaxel and Dep Irinotecan by end of calendar year 2022 at the 2021 AGM
As far as I see.....this has not changed
And I quote from today's webinar
"We are attempting to complete those trials in 2022"
Webinar this Friday 8th April with Jackie Fairley, page-42
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20455 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38876 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |